Lymphoblastic lymphoma in adults

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Understanding of the pathogenesis and biology of precursor T-cell and B-cell neoplasms has advanced significantly with the description of gene expression profiling studies, especially in T-cell disease. These studies have demonstrated leukemic arrest at various stages of thymocyte maturation, characterized by gene expression signatures with prognostic significance. Optimal treatment strategies for adult lymphoblastic lymphoma are uncertain, although current evidence supports the use of regimens similar to those used in acute lymphoblastic leukemia, with intensive induction therapy, central nervous system prophylaxis, and prolonged consolidation maintenance therapy. Current studies do not demonstrate a benefit from stem cell transplantation in first remission, although this approach is probably beneficial in relapsed disease. Identification of new therapeutic targets by further molecular studies is required.

Original languageEnglish (US)
Pages (from-to)241-247
Number of pages7
JournalCurrent Hematologic Malignancy Reports
Volume1
Issue number4
DOIs
StatePublished - Dec 1 2006
Externally publishedYes

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
T-Lymphoid Precursor Cells
Stem Cell Transplantation
Gene Expression Profiling
Thymocytes
Therapeutics
Transcriptome
B-Lymphocytes
Central Nervous System
T-Lymphocytes
Neoplasms

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Lymphoblastic lymphoma in adults. / Sweetenham, John W.

In: Current Hematologic Malignancy Reports, Vol. 1, No. 4, 01.12.2006, p. 241-247.

Research output: Contribution to journalArticle

@article{4667a09e7d1944ed9c86f2a27d7541bd,
title = "Lymphoblastic lymphoma in adults",
abstract = "Understanding of the pathogenesis and biology of precursor T-cell and B-cell neoplasms has advanced significantly with the description of gene expression profiling studies, especially in T-cell disease. These studies have demonstrated leukemic arrest at various stages of thymocyte maturation, characterized by gene expression signatures with prognostic significance. Optimal treatment strategies for adult lymphoblastic lymphoma are uncertain, although current evidence supports the use of regimens similar to those used in acute lymphoblastic leukemia, with intensive induction therapy, central nervous system prophylaxis, and prolonged consolidation maintenance therapy. Current studies do not demonstrate a benefit from stem cell transplantation in first remission, although this approach is probably beneficial in relapsed disease. Identification of new therapeutic targets by further molecular studies is required.",
author = "Sweetenham, {John W.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1007/s11899-006-0005-8",
language = "English (US)",
volume = "1",
pages = "241--247",
journal = "Current Hematologic Malignancy Reports",
issn = "1558-8211",
publisher = "Springer Science + Business Media",
number = "4",

}

TY - JOUR

T1 - Lymphoblastic lymphoma in adults

AU - Sweetenham, John W.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Understanding of the pathogenesis and biology of precursor T-cell and B-cell neoplasms has advanced significantly with the description of gene expression profiling studies, especially in T-cell disease. These studies have demonstrated leukemic arrest at various stages of thymocyte maturation, characterized by gene expression signatures with prognostic significance. Optimal treatment strategies for adult lymphoblastic lymphoma are uncertain, although current evidence supports the use of regimens similar to those used in acute lymphoblastic leukemia, with intensive induction therapy, central nervous system prophylaxis, and prolonged consolidation maintenance therapy. Current studies do not demonstrate a benefit from stem cell transplantation in first remission, although this approach is probably beneficial in relapsed disease. Identification of new therapeutic targets by further molecular studies is required.

AB - Understanding of the pathogenesis and biology of precursor T-cell and B-cell neoplasms has advanced significantly with the description of gene expression profiling studies, especially in T-cell disease. These studies have demonstrated leukemic arrest at various stages of thymocyte maturation, characterized by gene expression signatures with prognostic significance. Optimal treatment strategies for adult lymphoblastic lymphoma are uncertain, although current evidence supports the use of regimens similar to those used in acute lymphoblastic leukemia, with intensive induction therapy, central nervous system prophylaxis, and prolonged consolidation maintenance therapy. Current studies do not demonstrate a benefit from stem cell transplantation in first remission, although this approach is probably beneficial in relapsed disease. Identification of new therapeutic targets by further molecular studies is required.

UR - http://www.scopus.com/inward/record.url?scp=33846249355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846249355&partnerID=8YFLogxK

U2 - 10.1007/s11899-006-0005-8

DO - 10.1007/s11899-006-0005-8

M3 - Article

C2 - 20425319

AN - SCOPUS:33846249355

VL - 1

SP - 241

EP - 247

JO - Current Hematologic Malignancy Reports

JF - Current Hematologic Malignancy Reports

SN - 1558-8211

IS - 4

ER -